Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CIM

Chimera Investment Corp Raises Dividend to $0.37

Chimera Investment Corporation has declared its third quarter 2025 dividend of $0.37 per common share, payable on October 31, 2025, to stockholders of record on September 30, 2025. This represents a 2.78% increase from the second quarter 2025 dividend of $0.36 per common share.

Chimera's principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. The company primarily invests in diversified portfolios of mortgage assets, including residential mortgage loans, non-agency RMBS, agency RMBS, agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.

This announcement comes on the heels of the company's second quarter 2025 dividend declaration of $0.36 per common share, which was payable on July 31, 2025, to stockholders of record on June 30, 2025. Additionally, Chimera's second quarter 2025 core earnings were $0.52 per common share, while its GAAP net income was $0.42 per common share.

Chimera's commitment to delivering value to its stockholders is evident in its consistent dividend declarations and its focus on investment performance in the real estate sector. Today the company's shares have moved -0.04% to a price of $14.035. For the full picture, make sure to review CHIMERA INVESTMENT CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS